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Individual murine B cells express a wide range of Ia densities on the plasma membrane. Here
wedemonstrate that a dramatic increase in B-cell Ia could be induced byovernight exposure toan
uncharacterized lymphokine (LK). Membrane I-A and I-E molecules were both increased after
LK treatment, whereas membrane IgM remained unchanged. Twosubpopulations ofB cells were
identified, based on their requirements for expressing maximal Ia; one subpopulation required
only LK, the other required both LK and T cells in the overnight culture. Functional changes
accompanied the Ia increase. The functional capacity to present antigens to Tcells was lacking in
normal resting B cells, but was acquired following LK treatment.
We suggest that the LK-treated B cell has achieved a new differentiation state, one of
preparation for interaction with Tcells. We term this state the "poised" B cell, and propose that B
cells in the poised state may significantly contribute to T-cell activation as antigen-presenting
cells. Moreover, poised B cells may themselves find an advantage over normal B cells in
successfully acquiring T-cell help.
INTRODUCTION
The major histocompatibility gene complex has been found in many species since its
original description as a gene locuscontrolling immunological rejection oftransplanted
tissues. Over the past decade considerable effort has been directed toward understand-
ing the role of these gene products in immune responses. The I region of the mouse
major histocompatibility complex (reviewed in [1]) encodes the Ia antigens, consisting
oftwo glycoproteins, I-A and I-E, each composed of two peptide subunits. Ia antigens
are membrane proteins expressed on some cell types within the immune system,
including B cells, macrophages (MO), and dendritic cells, as well as being expressed on
some other cell types [2,3]. Ia on cells ofthe immune system is thought to enable these
cells to interact with T cells, which display receptors for Ia.
The density of Ia on cell membranes varies widely among cell types, dendritic cells
displaying the most, MO the least, whereas individual B cells express a wide rangeofIa
densities. The density of Ia, in addition to varying between cells of different lineages,
can also be modulated on individual cells. Thus, MO and some other cell types can be
stimulated by gamma interferon (IFN-,y) to increase Ia density [4,5], and by
endotoxin to reduce Ia [6]. The function ofIa modulation may represent a control over
theabilityofMO's (and othercells) to interactwith Tcells. Indeed, theMO-like tumor,
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P388D,, normally expresses no detectable membrane Ia and does not function as an
antigen-presenting cell (APC) for T-cell activation. Exposure to uncharacterized
lymphokines (probably IFN'y) is reported to induce P388D, to express membrane Ia,
and concomitantly to acquire APC function [7J.
In the present study, we report that B cells, like MO, can be stimulated by
lymphokines (LK) to express heightened levels of Ia, and that this Ia increase is
accompanied by theacquisition ofAPC function by Bcells. Based onthesefindings, we
propose that the resting B cell can be induced by LK to differentiate to a new state, a
state ofpreparation for interacting with T cells-what we term the "poised B cell."
MATERIALS AND METHODS
Mice
C57BL/6J and CBA/J mice were obtained from Jackson Laboratories (Bar
Harbor, ME).
Lymphokine Preparation
BALB/c spleen cells (107/ml) were cultured for 24 hours in RPMI 1640 and 10
percent fetal calf serum (Dutchland) containing concanavalin A (5 gg/ml, Sigma).
Lymphokine-containing supernatants (LK) were then collected, centrifuged, filtered
(0.45 micron, Nalge), a methyl-mannoside added (20 mg/ml, Sigma), and frozen at
-200C until use.
B-CellPurification
B cells were isolated from mouse spleen cell preparations by adherence to goat
anti-mouse Ig-coated plates [8]. Nonadherent cells were removed and the adherent
fraction was eluted by warming plates for one hour at 370C, followed by vigorous
pipetting. This popuiation was approximately 95 percent B cells as determined by
anti-Ig and anti-Ia staining and FACS analysis.
LK Treatment ofB Cells
Spleen cells or purified B cells werecultured (107/ml) overnight in RPMI 1640 with
10 percent fetal calf serum and 30 percent LK in one ml wells (Costar). In some
experiments the purified B cells (5 x 106/ml) were reconstituted with the Ig-coated
plate nonadherent cells (5 x 106/ml) prior to LK treatment. Cells were then washed
and assayed for I-A, I-E, and IgM expression. To assay their APC function, B cells
were similarly cultured (with LK and T cells); following the overnight culture, B cells
were purified and assayed for APC function.
Fluorescence-Activated CellSorter Analysis
Following the overnight culture with LK, B cells were analyzed for Ia density using
the FACS IV system (Becton-Dickinson). Cells were washed in phosphate-buffered
saline (PBS) (with 0.02 percent sodium azide) anddivided intoseveral staining groups.
Cells (3 x 106) were then treated with the following antibodies: (i) anti-I-Ak,
monoclonal 10-2-16; (ii) anti-I-Ek, monoclonal 14.4.4; and (iii) anti-IgM, polyclonal
rabbit anti-MOPC 104E, purified by affinity to 104E. Cells were incubated with
saturating concentrations of antibodies for 30 minutes at 40C, then washed twice in
PBS azide, and resuspended in 100 ,l ofbuffer containing a saturating concentration
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of FITC-protein A (Pharmacia) or FITC-rabbit anti-mouse IgG2a (Nordic). Follow-
ing 30 minutes' incubation at 40C, cells were washed, resuspended in one ml PBS
azide, then kept on ice, and immediately analyzed on the FACS IV. Twenty thousand
cells were analyzed for fluorescence intensity.
Antigen Presentation Assay
C57B6/6J mice were immunized with keyhole limpet hemacyanin (KLH) (100 ,ug,
Calbiochem) emulsified in complete Freund's adjuvant (Difco) subcutaneously at the
base of the tail. Seven days later, inguinal lymph nodes were removed and cell
suspensions prepared. To deplete APC, cells were treated with anti-I-Ab (clone Y3P,
[9]) followed by rabbit serum complement (Dutchland) at 370C for 30 minutes. Cells
were then placed in culture (5 x 105/200 ,l/well) with KLH (20 4g/ml) in RPMI
with 0.5 percent fresh syngeneic mouse serum in microtiter wells (Falcon). APC
function of unfractionated spleen cells, B cells, or LK-treated B cells was assessed by
treating them with mitomycin C (50 ug/ml, Sigma) for 30 minutes at 370C, washing,
and adding (105/well) toAPC-depleted culturesoflymph nodecells. Proliferation was
measured four days later by pulsing with 3H-TdR (1 uCi/well, NEN) followed by
harvesting on a MASH apparatus (Microbiological Associates), and counting on a
liquid scintillation counter.
RESULTS
LKStimulates Increased Ia Expression by B Cells
LK regulation ofB-cell Ia density was examined using overnight exposure ofsplenic
B cells to LK, followed by quantitation ofmembrane Ia using FACS analysis. Results
areshown in Fig. 1, indicating that untreated B cells displayed heterogeneous densities
of Ia. LK treatment resulted in increased densities of IA and IE on B cells. It appears
that a subpopulation of B cells (50 to 60 percent) were stimulated by LK to produce
maximal levels of Ia, while other B cells remained in the intermediate range of Ia
density. IgM density did not increase as a result of LK treatment, indicating a
selectivity ofthe LK effect on expression ofmembrane proteins.
The LK-induced change in Ia density represents a true increase, rather than a
protection from Ia loss during culture, since B-cell Ia density did not diminish during
culture in the absence of LK, but retained the Ia density profile of freshly isolated B
cells (not shown). It is also unlikely that the overnight culture with LK produced
high-Ia Bcells byeitherkilling low-Ia cells or stimulating proliferation ofhigh-Iacells,
since cell viability remained good after culture and very little proliferation occurs
during this period in cultured resting B cells.
We have identified several T cell lines and tumors which produce potent B
cell-Ia-inducing supernatants (not shown). Thus, T cells may be the relevant spleen
cell subpopulation producing the LK detected in the studies presented here. As yet, we
have no further information on the nature of the relevant LK. However, two reports
have recently appeared on the subject of LK induction of B cell Ia. Roehm et al. [10]
detected this LK activity in the supernatants of a T-cell hybridoma stimulated with
concanavalin A. In their study the molecular weight of the Ia-inducing LK roughly
corresponded to that of B-cell growth factor, and tests of interleukin-2 (IL-2) and
IFN'y (recombinant DNA products) failed to indicate Ia-inducing activity on B cells.
Further support for B-cell growth factor (renamed "B-cell stimulating factor") as the
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a B. Anti-l-EK FIG. 1. LK augments la expression
on B cells. Shown are fluorescence pro-
files of purified CBA/J splenic B cells
CO A1 following overnight incubation with
o , - LK. The LK-treated B cells were
stained with the indicated specific
E - - -. ~ _ss reagent (----) or for nonspecific binding
of the FITC-coupled second reagent Z C. Anti-p (....). Control B cells (incubated with
medium overnight) were also stained
specifically (i) or for nonspecific
fluorescence (-). Note the LK-
induced increase in B cell I-A"and I-Ek
- \-R _ \ expression with no change in M expres-
----- ...~ - sion. Note also that only about one-half
ofthe Bcells showed an increase in I-A"
Fluorescence Intensity and I-Ek density.
Ia-inducing LK for B cells comes from Noelle et al. [ 1] who used a relatively pure LK
preparation.
T Cells Augment the Ia Induction by LK
As shown in Fig. 1, not all ofthe purified B cells achieved uniformly high levels ofIa
after culture with LK. The same results were obtained when anti-Thy 1 + comple-
ment-treated spleen cells were used as a source of purified B cells (data not shown).
However, when T cells were included during the LK treatment of B cells (by adding
Ig-coated plate nonadherent cells to the purified B cells), Ia density became more
uniformly maximized, as shown in Fig. 2. Note that in the absence of T cells, LK
treatment produced two populations ofBcells which wedesignated I and II, expressing
normal and high Ia densities, respectively. In the presence of both T cells and LK, B
cells in zone I were apparently converted into zone II (the T cells can be seen in these
plots as the large Ia-negative peak to the left ofzone I). In the absence ofadded LK, T
cells induced a small increase in B-cell Ia (not shown).
How might T cells augment the LK action, as observed in Fig. 2? One possibility is
that they produce more ofthe LK, i.e., that we have notused an excess ofLK, and that
cultured T cells (or T cells activated by the added lymphokines) produce the optimal
LK concentration. On the other hand, a T cell may deliver a separate signal, different
from the LK, to amplify its effect. In either case, B cells were observed reproducibly to
fall into zones I and II, the former requiring both T cells and LK, the latter only LK, to
display maximal Ia densities. Although both IA (panel A) and IE (panel B) staining
indicated two populations of B cells, we have not yet determined whether the two
correspond, i.e., whether B cells with low IA also have low IE and those with high IA
also have high IE.
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FIG. 2. T cells augment the la induction
U ~ by LK. Purified CBA/J B cells (-) or B
o B. AntHEK cells + T cells (----) were incubated over-
night in medium + LK. Note the distinct
E populations of B cells with normal (I) and
z increased (II) I-Ak and I-Ek expression in the
./' \ ~ absence of T cells. When T cells were
included during LK exposure, all B cells
showed high I-Ak and I-Ek expression. (B
Fluorescence Intensity cells in zone I were converted into zone II.)
LK Treatment Induces APCFunction in B Cells
What is the functional significance ofincreased Ta on B cells? Antigen presentation
to T cells is known to require recognition ofTa on accessory cells. B cells, although they
express Ta, are inefficient APCs. We therefore tested whether LK treatment, which
increases Ia, would also improve the APC function of B cells. As shown in Fig. 3, this
proved to be the case. Primed LNC were depleted of IA+ cells, resulting in an
inhibition of their ability to proliferate when challenged with antigen; various
populations of mitomycin-C-treated cells were then tested for the ability to reconsti-
tute proliferation in the APC-depleted LNC. A preparation of unfractionated spleen
cells contained APC, as shown, presumably reflecting the dendritic cell or MO content.
On the other hand, normal splenic B cells were unable to reconstitute this response, as
shown; even when tenfold more B cells were used (not shown), no reconstitution was
observed. LK-treated B cells were, however, quite effective in restoring the response, as
shown, indicating an acquisition ofAPC function by B cells.
Since we have not as yet purified either the IA-inducing or APC-inducing LKs, we
do not know whether they are the same entity. Nevertheless, that LKs can induce APC
function in B cells is an intriguing finding and the observation that Ia increases occur
Additions to Culture cpm x -3
0 2 4 6 8
Whole LNC (-) KLH
Whole LNC + KLH
al-A LNC + KLH
al-A LNC + KLH + spleen -
cal-A LNC + KLH + B
al-A LNC + KLH + LK-B :: .. i
FIG. 3. Acquisition of APC function by C57BL/6 B cells.
KLH-primed lymph node cells (LNC) depleted of I-A+ cells (as
explained in Materials and Methods) werestimulated toprolifer-
ate in vitro in the presence of KLH + mitomycin C-treated
spleen cells or purified B cells. Note that only whole spleen cells
or LK-treated purified B cells presented the KLH to the LNC.
Normal, untreated B cells were unable to function as APCs.
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concomitantly suggests that the two processes may be related (similar conclusions were
recently reached by Roehm et al. [10]).
DISCUSSION
The Poised B Cell
We demonstrate here that B-cell Ia density is not fixed, but can be greatly increased
by LK and T cells. What is the functional significance of thisIa increase? Since one
function of Ia is thought to be in mediating cellular interactions with T cells [12], it is
reasonable to suppose that the high-Ia B cell is poised for such interaction. The ensuing
discussion will outline some possible advantages enjoyed by the poised B cell.
One consequence of an Ia increase on B cells may be acquisition of APC function,
which, as we show, occurs concomitantly with the Ia increase; but is APC function a
physiologically important property of splenic B cells, given the well-established
observation that other cells (e.g., dendritic cells [13]) in the spleen are effective APCs
and require no prior LK encounter to perform this function? How important is the B
cell as an APC? Possibly very important, but not in the spleen. Recent studies indicate
that chronic B-cell depletion of mice (by injection of anti-IgM antibodies from birth)
results in severe depression of T-cell priming in draining lymph nodes [14]; T-cell
priming can be restored in these mice if B cells are injected locally [Ron Y: personal
communication]. Wetherefore speculate that, in lymph nodes, T cells require B cells as
APC.
Thus, APC function may be an important, even critical property of B cells, but, as
shown in Fig. 3, untreated B cells fail to perform this function. Kakiuchi, Chesnut, and
Grey, who first reported APC function by B cells, also noted that resting B cells are
ineffective APCs and in their studies required activation by anti-Ig or lipopolysaccha-
ride (LPS) to display APC function [15]. We now show that LK-treated B cells are
effective APCs and suggest that it is this later mode-LK activation-by which B cells
become APCs in vivo, rather than via cross-linking of membrane Ig or by activation
with microbial products. Cross-linking membrane Ig would require that the antigen be
multivalent-probably an unusual property-and, moreover, would convert only a
miniscule proportion of B cells within the population (the antigen-specific clones) to
the APC phenotype. The ability of LPS to convert B cells to APC, while a potentially
important mechanism during bacterial infection, would not explain the requirement
for B cells in the priming oflymph node T cells by protein antigens as discussed above;
therefore, we propose that the LK mediates conversion of B cells to APC.
If B cells require the LK to become APC and if the LK is a product of activated T
cells, then it is reasonable to assume that, during an immune response, the LK-
producing T cells have already had an encounter with an APC prior to secreting the
LK. Hence, B cells may function as recruited or "secondary" APC. The advantage of
producing additional APC by this mechanism could lie in improving the likelihood of
furtherT-APCencounters or may be required in replacing exhausted "primary" APC;
thus, B cells may help expand and sustain T-cell immunity.
We must not assume that the observed increase in B-cell Ia represents the sine qua
non of APC function. The resting B cell already displays a significant density of Ia-a
higherdensity, in fact, than mostMO's in a population capable ofAPC function. Thus,
the observed Ia increase may be coordinated with, but not in itself constitute, the
critical characteristic of the antigen-presenting B cell. Another APC function which
could arise following LK treatment is the ability to produce IL-1; this product may
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perform an essential role in APC function [16,17]. Indeed, it has recently been
demonstrated that human B cells can be induced to secrete IL-I-like molecules [18].
Moreover, IL-I production by MO is controlled by Ia molecules on the cell membrane;
these Ia molecules may perform a receptor-like role in receiving T-cell stimuli [17,19].
Hence, by increasing its Ia, a B cell may become more sensitive to T-cell stimuli,
resulting in IL-I production; alternatively, increased Ia production may becoordinated
with competence for IL-I production.
Another APC function which may be lacking in normal B cellscould be the ability to
process antigens adequately; in the case of protein antigens, this processing may
generally involve uptake and proteolytic cleavage, followed by membrane display [20].
Additionally, APC function may involve cell surface molecules (as yet unknown)
required for interaction with T-cell membranes. Hence, LK treatment could stimulate,
in addition to an Ia increase, any number of properties in B cells, rendering them
competent to present antigens; we are currently evaluating several of these potential
properties.
Thus far, we havediscussed the poised B cell from the point ofviewofits action on T
cells, i.e., APC function. However, the LK-treated B cell, in addition to promoting
T-cell immunity as an APC, may also derive selfish benefits. Such poised B cells
displaying heightened Ia may have an improved likelihood of contact with helper T
cells. Consistent with this notion, it has been previously observed that B cells with high
la require fewer helper T cells to activate them than do low-Ia B cells [21]. Moreover,
wecould speculate that a poised B cell with APC functionwould insure that it is helped
by any T cell it encounters (eliminating the need for a third cell type to present
antigen) so long as the antigen required for that particular helper T cell is also present.
Hence, the poised B cell could activate its own helper T cell, then subsequently, while
in the same intimate contact, receive further helper stimuli, driving the B cell to
replicate and secrete immunoglobulin.
DEDICATION
As scientist, physician, and scholar, Elisha Atkins is our exemplar. But above all, he inspires us as
scientists, by infusing us with an awe and loveofnature. For us he has drawn the relationship ofthe scientist
to the natural world as a metaphysical contest pitted between man and his greatest intellectual adversary,
theplanofnature. Intrying timeswhen pettyaffairs would breakus, it is this romantic viewofourprofession
that will restore us, and that we would hope to transmit in some fractional part to our students after us. It is
for this contagious passion that we are most indebted to Elisha Atkins.
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